• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鸟枪法蛋白质组学揭示了黏多糖贮积症I型小鼠认知障碍的可能机制。

Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice.

作者信息

Baldo Guilherme, Lorenzini Daniel Macedo, Santos Diogenes Santiago, Mayer Fabiana Quoos, Vitry Sandrine, Bigou Stephanie, Heard Jean Michael, Matte Ursula, Giugliani Roberto

机构信息

Gene Therapy Center, Hospital de Clinicas de Porto Alegre, RS, Brazil.

Research Center in Molecular and Functional Biology, National Institute of Science and Technology on Tuberculosis, Pontifícia Universidade Católica do Rio Grande do Sul, RS, Brazil.

出版信息

Mol Genet Metab. 2015 Feb;114(2):138-45. doi: 10.1016/j.ymgme.2014.12.301. Epub 2014 Dec 13.

DOI:10.1016/j.ymgme.2014.12.301
PMID:25541102
Abstract

Mucopolysaccharidosis type I (MPS I) is due to deficient alpha-L-iduronidase (IDUA) which leads to storage of undegraded glycosaminoglycans (GAG). The severe form of the disease is characterized by mental retardation of unknown etiology. Trying to unveil the mechanisms that lead to cognitive impairment in MPS I, we studied alterations in the proteome from MPS I mouse hippocampus. Eight-month old mice presented increased LAMP-1 expression, GAG storage in neurons and glial cells, and impaired aversive and non-aversive memory. Shotgun proteomics was performed and 297 proteins were identified. Of those, 32 were differentially expressed. We found elevation in proteins such as cathepsins B and D; however their increase did not lead to cell death in MPS I brains. Glial fibrillary acid protein (GFAP) was markedly elevated, and immunohistochemistry confirmed a neuroinflammatory process that could be responsible for neuronal dysfunction. We didn't observe any differences in ubiquitin expression, as well as in other proteins related to protein folding, suggesting that the ubiquitin system is working properly. Finally, we observed alterations in several proteins involved in synaptic plasticity, including overexpression of post synaptic density-95 (PSD95) and reduction of microtubule-associated proteins 1A and 1B. These results together suggest that the cognitive impairment in MPS I mice is not due to massive cell death, but rather to neuronal dysfunction caused by multiple processes, including neuroinflammation and alterations in synaptic plasticity.

摘要

I型黏多糖贮积症(MPS I)是由于α-L-艾杜糖醛酸酶(IDUA)缺乏,导致未降解的糖胺聚糖(GAG)蓄积。该疾病的严重形式表现为病因不明的智力发育迟缓。为了揭示导致MPS I认知障碍的机制,我们研究了MPS I小鼠海马体蛋白质组的变化。8个月大的小鼠表现出溶酶体相关膜蛋白1(LAMP-1)表达增加、神经元和神经胶质细胞中GAG蓄积,以及厌恶和非厌恶记忆受损。我们进行了鸟枪法蛋白质组学分析,鉴定出297种蛋白质。其中32种蛋白质表达存在差异。我们发现组织蛋白酶B和D等蛋白质水平升高;然而它们的增加并未导致MPS I脑内细胞死亡。胶质纤维酸性蛋白(GFAP)明显升高,免疫组织化学证实存在可能导致神经元功能障碍的神经炎症过程。我们未观察到泛素表达以及其他与蛋白质折叠相关的蛋白质存在差异,这表明泛素系统功能正常。最后,我们观察到几种参与突触可塑性的蛋白质发生改变,包括突触后致密蛋白95(PSD95)过表达以及微管相关蛋白1A和1B减少。这些结果共同表明,MPS I小鼠的认知障碍并非由于大量细胞死亡,而是由多种过程导致的神经元功能障碍引起,包括神经炎症和突触可塑性改变。

相似文献

1
Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice.鸟枪法蛋白质组学揭示了黏多糖贮积症I型小鼠认知障碍的可能机制。
Mol Genet Metab. 2015 Feb;114(2):138-45. doi: 10.1016/j.ymgme.2014.12.301. Epub 2014 Dec 13.
2
Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.采用二维聚丙烯酰胺凝胶电泳对I型黏多糖贮积症小鼠脑进行蛋白质组学分析。
Mol Genet Metab. 2017 Jan-Feb;120(1-2):101-110. doi: 10.1016/j.ymgme.2016.10.001. Epub 2016 Oct 11.
3
Cathepsin B-associated Activation of Amyloidogenic Pathway in Murine Mucopolysaccharidosis Type I Brain Cortex.组织蛋白酶 B 相关的淀粉样蛋白生成途径在鼠脑黏多糖贮积症 I 型中的激活作用。
Int J Mol Sci. 2020 Feb 20;21(4):1459. doi: 10.3390/ijms21041459.
4
Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice.黏多糖贮积症Ⅰ型小鼠进行性运动功能障碍的证据。
Behav Brain Res. 2012 Jul 15;233(1):169-75. doi: 10.1016/j.bbr.2012.04.051. Epub 2012 May 9.
5
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity.I型黏多糖贮积症小鼠的进行性心脏病可能由组织蛋白酶B活性增加介导。
Cardiovasc Pathol. 2017 Mar-Apr;27:45-50. doi: 10.1016/j.carpath.2017.01.001. Epub 2017 Jan 6.
6
Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).黏多糖贮积症Ⅰ型(MPS I)小鼠模型不同脑区神经节苷脂代谢相关基因表达及膜脂改变。
Gene. 2013 Sep 15;527(1):109-14. doi: 10.1016/j.gene.2013.06.002. Epub 2013 Jun 15.
7
Intracerebroventricular transplantation of human bone marrow-derived multipotent progenitor cells in an immunodeficient mouse model of mucopolysaccharidosis type I (MPS-I).脑室内移植人骨髓多能祖细胞在黏多糖贮积症Ⅰ型(MPS-I)免疫缺陷小鼠模型中的应用。
Cell Transplant. 2012;21(7):1577-93. doi: 10.3727/096368912X636894.
8
High-dose enzyme replacement therapy in murine Hurler syndrome.高剂量酶替代疗法治疗鼠类黏多糖贮积症Ⅰ型。
Mol Genet Metab. 2014 Feb;111(2):116-22. doi: 10.1016/j.ymgme.2013.09.008. Epub 2013 Sep 19.
9
Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice.酶替代疗法从出生开始治疗可改善黏多糖贮积症 I 型小鼠中难以治疗的器官的预后。
Mol Genet Metab. 2013 May;109(1):33-40. doi: 10.1016/j.ymgme.2013.03.005. Epub 2013 Mar 16.
10
Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.黏多糖贮积症 I 型患者的成纤维细胞中残留的α-L-艾杜糖苷酸酶活性。
Mol Genet Metab. 2013 Aug;109(4):377-81. doi: 10.1016/j.ymgme.2013.05.016. Epub 2013 Jun 4.

引用本文的文献

1
Neuraminidase 1 secondary deficiency contributes to CNS pathology in neurological mucopolysaccharidoses via brain proteins hypersialylation.神经氨酸酶1继发性缺陷通过脑蛋白超唾液酸化作用导致神经黏多糖贮积症的中枢神经系统病理改变。
J Clin Invest. 2025 Jun 17. doi: 10.1172/JCI177430.
2
The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis.黏多糖贮积症中糖胺聚糖与半胱氨酸组织蛋白酶的相互作用
Biomedicines. 2023 Mar 7;11(3):810. doi: 10.3390/biomedicines11030810.
3
Proteomics in Inherited Metabolic Disorders.遗传性代谢紊乱中的蛋白质组学
Int J Mol Sci. 2022 Nov 25;23(23):14744. doi: 10.3390/ijms232314744.
4
Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.基于质谱的神经退行性溶酶体贮积症蛋白质组学。
Mol Omics. 2022 May 11;18(4):256-278. doi: 10.1039/d2mo00004k.
5
Innate Immunity in Mucopolysaccharide Diseases.黏多糖贮积症中的先天性免疫
Int J Mol Sci. 2022 Feb 11;23(4):1999. doi: 10.3390/ijms23041999.
6
Differences in MPS I and MPS II Disease Manifestations.黏多糖贮积症 I 型和 II 型临床表现的差异。
Int J Mol Sci. 2021 Jul 23;22(15):7888. doi: 10.3390/ijms22157888.
7
Synaptic Function and Dysfunction in Lysosomal Storage Diseases.溶酶体贮积病中的突触功能与功能障碍
Front Cell Neurosci. 2021 Mar 4;15:619777. doi: 10.3389/fncel.2021.619777. eCollection 2021.
8
Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.载有 PBA 纳米粒子的初步开发结果及其对接受化学诱导的慢性 MSUD 模型的大鼠氧化应激和神经炎症的影响。
Metab Brain Dis. 2021 Jun;36(5):1015-1027. doi: 10.1007/s11011-021-00686-8. Epub 2021 Feb 23.
9
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy.黏多糖贮积症发病机制中的组织蛋白酶:治疗的新视角。
Cells. 2020 Apr 15;9(4):979. doi: 10.3390/cells9040979.
10
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression.溶酶体贮积病的神经病理生理学:突触功能障碍作为疾病进展的起点
J Clin Med. 2020 Feb 25;9(3):616. doi: 10.3390/jcm9030616.